Market Report Source

Overview

Introduction

GPC Biotech (GPC), founded in 1997, has a business model relied on two pillars, as a service provider for preclinical research and as a product company with its own development pipeline. Later, the company changed its focus by developing a platform of base technologies, LeadCode, through collaborations with pharmaceutical partners and through the support of its own drug development projects.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

GPC is a biopharmaceutical company focused on discovery, development and commercialization of new anticancer drugs, Cell Cycle Inhibitors and antibodies against MHC class II-positive tumor cells. It’s most advanced product candidate satraplatin is currently in SPARC Phase III trial, for the treatment of hormone-refractory prostate cancer. The company’s second lead product candidate, 1D09C3, is in Phase I clinical trials and is a monoclonal antibody indicated for the treatment of relapsed/refractory B-cell lymphomas, such as Hodgkin’s and non-Hodgkin’s lymphomas and chronic lymphocytic leukemia. The company’s total revenues increased at a CAGR of 1.3% during 2002-2006, from $27.6 million to $29.1 million. This represents an absolute total growth of +$1.5 million during the historical period. The company’s biggest contributor to revenue growth during 2002-2006 was license, collaboration and other revenues.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company’s adjusted five year financial data along with key ratios and market capitalization.

Table of Contents

Overview
Catalyst
Summary
Company Structure
Company Overview and Key Facts
Business Description
History
Locations and Subsidiaries
Company Financials
Stock Market Performance
P&L
Balance Sheet
Cash Flow
Business Segment Performance
Products & Services
Pipeline Products
Competitors and Strategic Business Relationships
Key Competitors
Key Suppliers
Key Clients
Strategy
Company View
Corporate Strategy
SWOT Analysis
Overview
Strengths
Weaknesses
Opportunities
Threats
Value Chain Analysis
Overview
Discovery and Product Development
Key Employees
List of Key Employees
Key Employee Biographies
Financial and Operational Overview
Financial and Operational Overview

APPENDIX
Ask the analyst
Datamonitor consulting
Disclaimer

FIGURES
Figure 1: GPC – Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)

TABLES
Table 1: GPC – Key Facts
Table 2: GPC – Locations and Subsidiaries
Table 3: GPC – Year-End Share Price and Market Capitalization, 2002-2006 ($)
Table 4: GPC – Key Events Impacting Share Price Performance
Table 5: GPC – Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
Table 6: GPC – Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
Table 7: GPC – Balance Sheet, 2002-2006 ($ Mn)
Table 8: GPC – Cash Flow, 2002-2006 ($ Mn)
Table 9: GPC – Revenue Breakdown by Division, 2002-2006 ($ Mn)
Table 10: GPC – In-house Pipeline Products
Table 11: GPC – Collaboration Products
Table 12: GPC – Key Competitors
Table 13: GPC – Key Suppliers
Table 14: GPC – Key Clients
Table 15: GPC – SWOT Analysis Summary
Table 16: GPC – Value Chain Analysis
Table 17: GPC – Key Employees
Table 18: GPC – Financial and Operational Overview